{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:42:45Z","timestamp":1790959365976,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006940","name":"University of Mississippi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006940","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics: X"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ijpx.2021.100074","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T15:28:26Z","timestamp":1615130906000},"page":"100074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Formulation development of itraconazole PEGylated nano-lipid carriers for pulmonary aspergillosis using hot-melt extrusion technology"],"prefix":"10.1016","volume":"3","author":[{"given":"Gauri","family":"Shadambikar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushrut","family":"Marathe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mashan","family":"Almutairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Bandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahavir","family":"Chougule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Repka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpx.2021.100074_bb0005","article-title":"Intravenous itraconazole emulsions produced by SolEmuls technology","author":"Akkar","year":"2003","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpx.2021.100074_bb0010","article-title":"Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis","author":"Alvarez","year":"2007","journal-title":"J. Inf. Secur."},{"key":"10.1016\/j.ijpx.2021.100074_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2016.12.015","article-title":"A novel approach for the development of a nanostructured lipid carrier formulation by hot-melt extrusion technology","author":"Bhagurkar","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2021.100074_bb0020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-3659(02)00370-X","article-title":"Nebulization of biodegradable nanoparticles: Impact of nebulizer technology and nanoparticle characteristics on aerosol features","volume":"86","author":"Dailey","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2021.100074_bb0025","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-017-0864-4","article-title":"Excipient stability in oral solid dosage forms: a review","author":"Darji","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpx.2021.100074_bb0030","doi-asserted-by":"crossref","DOI":"10.2217\/nnm.12.129","article-title":"Transport of nanoparticles in cystic fibrosis sputum and bacterial biofilms by single-particle tracking microscopy","author":"Forier","year":"2013","journal-title":"Nanomedicine."},{"key":"10.1016\/j.ijpx.2021.100074_bb0035","doi-asserted-by":"crossref","DOI":"10.1080\/13693780802510232","article-title":"Invasion of the alveolar-capillary barrier by Aspergillus spp.: Therapeutic and diagnostic implications for immunocompromised patients with invasive pulmonary aspergillosis","author":"Hope","year":"2009","journal-title":"Med. Mycol."},{"key":"10.1016\/j.ijpx.2021.100074_bb0040","doi-asserted-by":"crossref","DOI":"10.1080\/17425247.2019.1609448","article-title":"An update on the contribution of hot-melt extrusion technology to novel drug delivery in the twenty-first century: part I","author":"Kallakunta","year":"2019","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpx.2021.100074_bb0045","doi-asserted-by":"crossref","DOI":"10.1183\/09059180.00001011","article-title":"Pulmonary aspergillosis: a clinical review","author":"Kousha","year":"2011","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.ijpx.2021.100074_bb0050","article-title":"Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications","author":"Labiris","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijpx.2021.100074_bb0055","article-title":"Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications","author":"Labiris","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijpx.2021.100074_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpx.2021.100074_bb0065","doi-asserted-by":"crossref","DOI":"10.1080\/03639045.2017.1313858","article-title":"A review of co-milling techniques for the production of high dose dry powder inhaler formulation","author":"Lau","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpx.2021.100074_bb0070","doi-asserted-by":"crossref","DOI":"10.2147\/IJN.S57565","article-title":"Formulation and delivery of itraconazole to the brain using a nanolipid carrier system","author":"Lim","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijpx.2021.100074_bb0075","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dki222","article-title":"The place for itraconazole in treatment","author":"Maertens","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpx.2021.100074_bb0080","article-title":"Nebulization of Fluids of Different Physicochemical Properties with Air-Jet and Ultrasonic Nebulizers","author":"McCallion","year":"1995","journal-title":"Pharm. Res. An Off. J. Am. Assoc. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2021.100074_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/S0378-5173(02)00180-1","article-title":"Nanostructured lipid matrices for improved microencapsulation of drugs","author":"M\u00fcller","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2021.100074_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/S0378-5173(02)00035-2","article-title":"Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN) - effect of surfactants, storage time and crystallinity","author":"Olbrich","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2021.100074_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.coche.2015.11.006","article-title":"PEGylation of PLA nanoparticles to improve mucus-penetration and colloidal stability for oral delivery systems","author":"Palacio","year":"2016","journal-title":"Curr. Opin. Chem. Eng."},{"key":"10.1016\/j.ijpx.2021.100074_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2008.10.003","article-title":"Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products","author":"Pardeike","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2021.100074_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2011.07.040","article-title":"Development of an Itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application","author":"Pardeike","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2021.100074_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2016.07.018","article-title":"Itraconazole-loaded nanostructured lipid carriers (NLC) for pulmonary treatment of aspergillosis in falcons","author":"Pardeike","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpx.2021.100074_bb0115","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-016-1890-8","article-title":"Characterization of solid dispersion of itraconazole prepared by solubilization in concentrated aqueous solutions of weak organic acids and drying","author":"Parikh","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpx.2021.100074_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/S0076-6879(09)64009-X","article-title":"Nanoliposomal dry powder formulations","author":"Patel","year":"2009","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ijpx.2021.100074_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2014.05.024","article-title":"Continuous manufacturing of solid lipid nanoparticles by hot melt extrusion","author":"Patil","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2021.100074_bb0130","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-014-9674-8","article-title":"Continuous production of Fenofibrate solid lipid nanoparticles by hot-melt extrusion technology: a systematic study based on a quality by design approach","author":"Patil","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.ijpx.2021.100074_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2010.02.006","article-title":"Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers","author":"Patlolla","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2021.100074_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/0169-409X(95)00113-L","article-title":"Mechanisms of macromolecule absorption by the lungs","author":"Patton","year":"1996","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpx.2021.100074_bb0145","doi-asserted-by":"crossref","first-page":"16495","DOI":"10.1021\/acs.jpcc.9b00913","article-title":"What does nanoparticle stability mean?","volume":"123","author":"Phan","year":"2019","journal-title":"J. Phys. Chem. C"},{"key":"10.1016\/j.ijpx.2021.100074_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2010.03.017","article-title":"Formulation strategy and use of excipients in pulmonary drug delivery","author":"Pilcer","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2021.100074_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/jps.22416","article-title":"Development, characterization, and in vitro and in vivo evaluation of benzocaine- and lidocaine-loaded nanostructrured lipid carriers","author":"Puglia","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2021.100074_bb0160","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1080\/03639040701525627","article-title":"Pharmaceutical applications of Hot-Melt Extrusion: Part II","volume":"33","author":"Repka","year":"2007","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpx.2021.100074_bb0165","doi-asserted-by":"crossref","DOI":"10.1517\/17425240802583421","article-title":"Applications of hot-melt extrusion for drug delivery","author":"Repka","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.ijpx.2021.100074_bb0170","first-page":"45","article-title":"Cellular uptake of coumarin-6 as a model drug loaded in solid lipid nanoparticles","volume":"62","author":"Rivolta","year":"2011","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.ijpx.2021.100074_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2013.01.064","article-title":"Nanoparticle diffusion in respiratory mucus from humans without lung disease","author":"Schuster","year":"2013","journal-title":"Biomaterials."},{"key":"10.1016\/j.ijpx.2021.100074_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12111019","article-title":"Vacuum compression molding as a screening tool to investigate carrier suitability for hot-melt extrusion formulations","author":"Shadambikar","year":"2020","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ijpx.2021.100074_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-020-01916-5","article-title":"Novel Application of Hot Melt Extrusion Technology for Preparation and Evaluation of Valacyclovir Hydrochloride Ocular Inserts","volume":"22","author":"Shadambikar","year":"2021","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpx.2021.100074_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2010.08.014","article-title":"Production & stability of stavudine solid lipid nanoparticles - from lab to industrial scale","author":"Shegokar","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2021.100074_bb0195","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-015-9723-y","article-title":"Scientific and regulatory standards for assessing product performance using the similarity factor, f2","author":"Stevens","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.ijpx.2021.100074_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2008.12.076","article-title":"The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles","author":"Suk","year":"2009","journal-title":"Biomaterials."},{"key":"10.1016\/j.ijpx.2021.100074_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpx.2021.100074_bb0210","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1517\/17425247.2016.1126246","article-title":"Contribution of hot-melt extrusion technology to advance drug delivery in the 21st century","volume":"13","author":"Tiwari","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpx.2021.100074_bb0215","unstructured":"USP Monograph [WWW Document], 2021, URL http:\/\/usp35.infostar.com.cn\/uspnf\/pub\/data\/v35300\/usp35nf30s0_m43724.html."},{"key":"10.1016\/j.ijpx.2021.100074_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2008.02.011","article-title":"Inhaled nanoparticles-a current review","author":"Yang","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2021.100074_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2020.102002","article-title":"Approaches for developing acyclovir gastro-retentive formulations using hot melt extrusion technology","author":"Zhang","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."}],"container-title":["International Journal of Pharmaceutics: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156721000037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156721000037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T02:40:21Z","timestamp":1762915221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590156721000037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":45,"alternative-id":["S2590156721000037"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpx.2021.100074","relation":{},"ISSN":["2590-1567"],"issn-type":[{"value":"2590-1567","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Formulation development of itraconazole PEGylated nano-lipid carriers for pulmonary aspergillosis using hot-melt extrusion technology","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpx.2021.100074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100074"}}